Effect of repeated detrusor onabotulinumtoxina injections on bladder and renal function in patients with chronic spinal cord injuries

Neurourology and Urodynamics

Volumn 30, Issue 8, 2011, Pages 1541-1545

  Kuo, Hann Chorng ^a   Liu, Shu Hsin ^a  

^a TZU CHI UNIVERSITY   (Taiwan)

Author keywords

detrusor sphincter dyssynergia; neurogenic bladder; renal function; spinal cord injury

Indexed keywords

BOTULINUM TOXIN A; PENTETATE TECHNETIUM TC 99M;

ADULT; ARTICLE; BLADDER CAPACITY; BLADDER COMPLIANCE; BLADDER FUNCTION; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DETRUSOR DYSSYNERGIA; DETRUSOR MUSCLE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEMATURIA; HUMAN; INCONTINENCE; INTERMITTENT CATHETERIZATION; KIDNEY FUNCTION; KIDNEY SCINTISCANNING; MALE; QUALITY OF LIFE; QUALITY OF LIFE INDEX; SPINAL CORD INJURY; URINARY TRACT INFECTION; URINE INCONTINENCE;

ADMINISTRATION, INTRAVESICAL; ADOLESCENT; ADULT; BOTULINUM TOXINS, TYPE A; CHRONIC DISEASE; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INTERMITTENT URETHRAL CATHETERIZATION; KIDNEY; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; PILOT PROJECTS; PRESSURE; QUALITY OF LIFE; QUESTIONNAIRES; RADIOPHARMACEUTICALS; SPINAL CORD INJURIES; TAIWAN; TECHNETIUM TC 99M PENTETATE; TIME FACTORS; TREATMENT OUTCOME; URINARY BLADDER; URINARY BLADDER, NEUROGENIC; URINARY INCONTINENCE; URODYNAMICS; YOUNG ADULT;

EID: 80054808209     PISSN: 07332467     EISSN: 15206777     Source Type: Journal    
DOI: 10.1002/nau.21146     Document Type: Article

References (29)

1. Weld KJ, Graney MJ, Dmochowski RR,. Clinical significance of detrusor sphincter dyssynergia type in patients with post-traumatic spinal cord injury. Urology 2000; 56: 565-68.
2. Ahmed HU, Shergill IS, Arya M, et al. Management of detrusor-external sphincter dyssynergia. Nat Clin Pract Urol 2006; 3: 368-80.
3. Weld KJ, Dmochowski RR,. Association of level of injury and bladder behavior in patients with post-traumatic spinal cord injury. Urology 2000; 55: 490-94.
4. Ethans KD, Nance PW, Bard RJ, et al. Efficacy and safety of tolterodine in people with neurogenic detrusor overactivity. J Spinal Cord Med 2004; 27: 214-18.
5. Pettersson-Hammerstad K, Jonsson O, Svennung IB, et al. Impaired renal function in newly spinal cord injured patients improves in the chronic stateâeffect of clean intermittent catheterization? J Urol 2008; 180: 187-91.
6. Schurch B, Stohrer M, Kramer G, et al. Botulinum A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drug? Preliminary results. J Urol 2000; 164: 692-97.
7. Del Popolo G, Filocamo MT, Li Marzi V, et al. Neurogenic detrusor overactivity treated with English botulinum toxin a: 8-year experience of one single centre. Eur Urol 2008; 53: 1013-19.
8. Patki PS, Hamid R, Arumugam K, et al. Botulinum toxin-type A in the treatment of drug-resistant neurogenic detrusor overactivity secondary to traumatic spinal cord injury. BJU Int 2006; 98: 77-82.
9. Kuo HC,. Therapeutic effects of suburothelial injection of botulinum a toxin for neurogenic detrusor overactivity due to chronic cerebrovascular accident and spinal cord lesions. Urology 2006; 67: 232-36.
10. Reitz A, Stohrer M, Kramer G, et al. European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol 2004; 45: 510-15.
11. Schulte-Baukloh H, Weíss C, Stolze T, et al. Botulinum-A toxin detrusor and sphincter injection in treatment of overactive bladder syndrome: objective outcome and patient satisfaction. Eur Urol 2005; 48: 984-90.
12. Schurch B, de Seze M, Denys P, et al. Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J Urol 2005; 174: 196-200.
13. Grosse J, Kramer G, Stohrer M,. Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence. Eur Urol 2005; 47: 653-59.
14. Gates GF,. Glomerular filtration rate: estimation from fractional accumulation of 99mTC-DTPA (Stannous). AJR 1982; 138: 565-70.
15. Uebersax JS, Wyman JF, Shumaker SA, et al. Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program for Women Research Group. Neurourol Urodyn 1995; 14: 131-39.
16. Cockett A, Aso Y, Denis L, et al. Recommendation of the International Consensus Committee concerning: 1. Prostate symptom score and quality of life assessment. In:, Cockett ATK, Khoury S, Aso Y, eds. Proceedings, The 2nd International Consultation on Benign Prostatic Hyperplasia (BPH), Paris, June 27-30 1993. Jersey: Channel Island, Scientific Communication International Ltd; 1994. p. 553-55.
17. Coyne KS, Matza LS, Kopp Z, et al. The validation of the patient perception of bladder condition (PPBC): a single-item global measure for patients with overactive bladder. Eur Urol 2006; 49: 1079-86.
18. Ruffion A, Villar E, Denys P, et al. Renal failure and neurogenic bladder. Prog Urol 2007; 17: 424-30.
19. Sekar P, Wallace DD, Waites KB, et al. Comparison of long-term renal function after spinal cord injury using different urinary management methods. Arch Phys Med Rehabil 1997; 78: 992-97.
20. Gerridzen RG, Thijssen AM, Dehoux E,. Risk factors for upper tract deterioration in chronic spinal cord injury patients. J Urol 1992; 147: 416-18.
21. Weld KJ, Graney MJ, Dmochowski RR,. Differences in bladder compliance with time and associations of bladder management with compliance in spinal cord injured patients. J Urol 2000; 163: 1228-33.
22. Giannantoni A, Scivoletto G, Di Stasi SM, et al. Clean intermittent catheterization and prevention of renal disease in spinal cord injury patients. Spinal Cord 1998; 36: 29-32.
23. Pannek J, Sommerfeld HJ, Botel U, et al. Combined intravesical and oral oxybutynin chloride in adult patients with spinal cord injury. Urology 2000; 55: 358-62.
24. Nosseir M, Hinkel A, Pannek J,. Clinical usefulness of urodynamic assessment for maintenance of bladder function in patients with spinal cord injury. Neurourol Urodyn 2007; 26: 228-33.
25. Razdan S, Leboeuf L, Meinbach DS, et al. Current practice patterns in the urologic surveillance and management of patients with spinal cord injury. Urology 2003; 61: 893-96.
26. Linsenmeyer TA, Bagaria SP, Gendron B,. The impact of urodynamic parameters on the upper tracts of spinal cord injured men who void reflexly. J Spinal Cord Med 1998; 21: 15-20.
27. Schurch B, Hauri D, Rodic B, et al. Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: a prospective study in 24 spinal cord injury patients. J Urol 1996; 155: 1023-29.
28. Kuo HC,. Botulinum A toxin urethral injection for the treatment of lower urinary tract dysfunction. J Urol 2003; 170: 1908-12.
29. MacDiarmid SA, McIntyre WJ, Anthony A, et al. Monitoring of renal function in patients with spinal cord injury. BJU Int 2000; 85: 1014-18.